Information  X 
Enter a valid email address

AstraZeneca PLC (AZN)

  Print      Mail a friend       Annual reports

Monday 28 September, 2015

AstraZeneca PLC

Director/PDMR Shareholding

RNS Number : 4006A
AstraZeneca PLC
28 September 2015

Transactions by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4


On 25 September 2015, Dr Sean Bohen, EVP, Global Medicines Development & Chief Medical Officer, a person discharging managerial responsibilities, was granted awards under the terms of the AstraZeneca Performance Share Plan (AZPSP) and the AstraZeneca Restricted Share Plan (AZRSP) over the Company's American Depositary Shares (ADSs). Two ADSs equal one Ordinary Share of US$0.25 each.




ADSs awarded under AZPSP

ADSs awarded under AZRSP

Award price per ADS


Sean Bohen








The AZPSP award is subject to a combination of performance measures focused on AstraZeneca's scientific, commercial and financial performance assessed over a three-year performance period (1 January 2015 to 31 December 2017). The award will vest on the third anniversary of the date on which it was granted.


The AZRSP award will vest, subject to Dr Bohen's continued employment with the Company, as follows:


25,901 ADSs will vest on 25 September 2016

25,901 ADSs will vest on 25 September 2017



A C N Kemp

Company Secretary

28 September 2015


This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t